Gwendolyn K. Binder
Net Worth

Last updated:

What is Gwendolyn K. Binder net worth?

The estimated net worth of Dr. Gwendolyn K. Binder is at least $3,603,135 as of 19 Jan 2024. He owns shares worth $32,986 as insider, has earned $1,694,759 from insider trading and has received compensation worth at least $1,875,390 in Cabaletta Bio, Inc..

What is the salary of Gwendolyn K. Binder?

Dr. Gwendolyn K. Binder salary is $625,130 per year as Executive Vice President of Science & Technology in Cabaletta Bio, Inc..

How old is Gwendolyn K. Binder?

Dr. Gwendolyn K. Binder is 50 years old, born in 1975.

What stocks does Gwendolyn K. Binder currently own?

As insider, Dr. Gwendolyn K. Binder owns shares in one company:

Company Title Shares Price per share Total value
Cabaletta Bio, Inc. (CABA) Executive Vice President of Science & Technology 20,000 $1.65 $32,986

What does Cabaletta Bio, Inc. do?

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. It has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.

Gwendolyn K. Binder insider trading

Cabaletta Bio, Inc.

Dr. Gwendolyn K. Binder has made 16 insider trades between 2022-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 22,000 units of CABA stock on 19 May 2023. As of 19 Jan 2024 he still owns at least 20,000 units of CABA stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 11,000 $1.01 $11,110
Sale
Common Stock 10,300 $19.54 $201,211
Sale
Common Stock 700 $20.33 $14,229
Option
Stock Option (Right to Buy) 11,000 $1.01 $11,110
Option
Stock Option (Right to Buy) 11,000 $1.01 $11,110
Option
Common Stock 11,000 $1.01 $11,110
Sale
Common Stock 3,132 $22.22 $69,593
Sale
Common Stock 7,868 $21.76 $171,200
Sale
Common Stock 3,542 $17.39 $61,610
Sale
Common Stock 7,458 $18.02 $134,408
Option
Common Stock 11,000 $1.01 $11,110
Option
Stock Option (Right to Buy) 11,000 $1.01 $11,110
Option
Common Stock 11,000 $1.01 $11,110
Option
Stock Option (Right to Buy) 11,000 $1.01 $11,110
Sale
Common Stock 10,592 $13.32 $141,096
Sale
Common Stock 408 $14.28 $5,825
Option
Stock Option (Right to Buy) 11,000 $1.01 $11,110
Sale
Common Stock 10,300 $17.5 $180,271
Sale
Common Stock 700 $18.5 $12,950
Option
Common Stock 11,000 $1.01 $11,110
Option
Stock Option (Right to Buy) 11,000 $1.01 $11,110
Sale
Common Stock 10,700 $13.41 $143,434
Option
Common Stock 11,000 $1.01 $11,110
Sale
Common Stock 300 $13.82 $4,147
Sale
Common Stock 2,815 $14.26 $40,142
Sale
Common Stock 8,185 $13.67 $111,881
Option
Common Stock 11,000 $1.01 $11,110
Option
Stock Option (Right to Buy) 11,000 $1.01 $11,110
Option
Common Stock 11,000 $1.01 $11,110
Option
Stock Option (Right to Buy) 11,000 $1.01 $11,110
Sale
Common Stock 11,000 $12.99 $142,923
Sale
Common Stock 22,000 $11.81 $259,842
Option
Stock Option (Right to Buy) 22,000 $1.01 $22,220
Option
Common Stock 22,000 $1.01 $22,220
Purchase
Common Stock 20,000 $1 $19,900

Cabaletta Bio key executives

Cabaletta Bio, Inc. executives and other stock owners filed with the SEC: